Japan Bariatric Surgery Devices Market Analysis

Japan Bariatric Surgery Devices Market Executive Summary

The Japan Bariatric Surgery Devices Market is at around $165.3 Mn in 2023 and is projected to reach $243.7 Mn in 2030, exhibiting a CAGR of 5.7% during the forecast period 2023-2030.

The purpose of gastric bypass and other weight-loss surgeries, often known as bariatric or metabolic surgery, is to alter your digestive system in order to help you lose weight. Bariatric surgery is done if diet and exercise haven't improved your weight-related health problems. The amount of food you can eat is limited by some diet plans. Some work by reducing the body's ability to absorb fat and calories. Certain methods serve both purposes. While there are numerous advantages to bariatric surgery, there are risks and adverse effects associated with any large weight-loss procedure. For bariatric surgery to be successful in the long run, you must also engage in regular exercise and make long term, healthy dietary modifications. Bariatric surgery poses potential health risks, both in the short term and the long term. Bariatric surgery risks can include excessive bleeding, infection, reactions to anaesthesia, blood clots, lung or breathing problems etc. Longer-term risks and complications of weight-loss surgery vary depending on the type of surgery. they can include bowel obstruction, dumping syndrome, a condition that leads to diarrhoea, flushing, light-headedness, nausea or vomiting, gallstones, hernias, hypoglycaemia, malnutrition, ulcers etc.

According to World Obesity Observatory on 4.5% of population is obese in Japan. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Medtronic, B. Braun, Olympus Corporation, Fujifilm Holding Corporation, Cousin Surgery among others.

Market Dynamics

Market Drivers

Technological developments in equipment used in bariatric surgery: Ongoing innovations in surgical techniques and technology are enhancing the safety, efficacy, and minimally invasive nature of bariatric procedures. For example, advanced laparoscopic and robotic-assisted surgical tools are leading to quicker recovery times and improved surgical outcomes.

Rising obesity rates in Japan: According to World Obesity Observatory on 4.5% of population is obese in Japan. This is, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Increasing awareness of health risks associated with obesity: People are increasingly aware of the severe health issues associated with obesity, such as type 2 diabetes, heart disease, and some cancers. This growing awareness is leading more individuals to look for effective long-term weight loss options, such as bariatric surgery.

Market Restraints

Potential complications and risks of surgical procedures: Like any major surgery, bariatric procedures carry risks such as infection, bleeding, and adverse reactions to anaesthesia. Long-term complications like nutritional deficiencies and dumping syndrome can also occur. These risks may deter some patients from pursuing surgical options.

Limited availability of skilled bariatric surgeons: There's a shortage of surgeons specially trained in bariatric procedures in Japan, leading to long wait times in some regions. This shortage limits market growth and patient access to these treatments.

Regulatory Approval Process: The regulatory environment in Japan can be stringent, with a complex and time-consuming approval process for medical devices, including bariatric surgery devices. This regulatory process leads to delays in the introduction of new devices, which hinder the market growth and availability

Regulatory Landscape and Reimbursement Scenario

Pharmaceuticals and Medical Devices Agency (PMDA) plays a central role in reviewing and approving medical devices, including those used in bariatric surgery. The Ministry of Health, Labour and Welfare (MHLW) oversees the healthcare system and sets policies for medical device regulation and reimbursement. The Central Social Insurance Medical Council advises the MHLW on healthcare reimbursement policies and pricing.

The Japan Society for the Study of Obesity (JASSO) provides clinical guidelines and recommendations for obesity treatment, including bariatric procedures. The Medical Device Evaluation Office within the MHLW's Pharmaceutical Safety and Environmental Health Bureau is responsible for the classification and regulatory oversight of medical devices. The Health Insurance Bureau of the MHLW manages the national health insurance system and influences reimbursement decisions. The Japanese Association for Metabolic and Bariatric Surgery (JAMS) contributes to professional standards and advocacy for bariatric procedures. The Advanced Medical Care Program, administered by the MHLW, can provide a pathway for coverage of new medical technologies not yet included in the national health insurance.

Competitive Landscape

Key Players

Here are some of the major key players in the Japan Bariatric Surgery Devices Market:

• Olympus Corporation
• TOP Corporation
• Fujifilm Holding Corporation
• Terumo
• Medtronic plc.
• Ethicon, Inc. (Johnson & Johnson)
• B Braun
• Cousin Surgery
• SPATZ FIGA, Inc.
• Teleflex Incorporated